Literature DB >> 8894785

Additive effect of diabetes and systemic hypertension on the immune mechanisms of atherosclerosis.

S Mantov1, D Raev.   

Abstract

In order to evaluate the changes in humoral immunity due to one and two atherogenic factors (systemic hypertension and/or diabetes mellitus), we investigated 350 women divided into four groups: (1) 65 insulin-dependent (type I) non-hypertensive diabetics; (2) 92 systemic hypertensive non-diabetic subjects; (3) 64 hypertensive insulin-dependent diabetics; and (4) 129 non-hypertensive and non-diabetic women as a control group. All subjects had no coronary artery disease. The humoral immunity was evaluated by (1) circulating immune complexes, (2) total serum complement, (3) C3 fraction of complement, and (4) circulating antitissue antibodies (antivascular and antisclerotic-vascular). The patients with atherosclerotic risk factors (diabetes and/or hypertension) had significantly (P < 0.001) elevated levels of total complement, C3 fraction and circulating complexes compared with the control group. Total complement and circulating complexes levels were most elevated in patients with a combination of diabetes and hypertension. Similarly, these patients had the highest frequency of antitissue antibodies. In summary, the parameters of humural immunity were more changed in patients with two risk factors (diabetes and hypertension) compared to patients with only one risk factor. It is possible that these immunological changes appeared earlier than clinical symptoms of atherosclerosis and they could be used as an early prognostic test for predisposition to atherosclerotic vascular complications.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8894785     DOI: 10.1016/0167-5273(96)02706-4

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Role of infectious and immune factors in coronary and cerebrovascular arteriosclerosis.

Authors:  Claudia Stöllberger; Josef Finsterer
Journal:  Clin Diagn Lab Immunol       Date:  2002-03

2.  Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein.

Authors:  Takayuki Fujita; Takayuki Fujioka; Tetsuo Murakami; Atsushi Satomura; Yoshinobu Fuke; Koichi Matsumoto
Journal:  J Clin Lab Anal       Date:  2007       Impact factor: 2.352

3.  Anti-cardiolipin antibodies and circulating immune complexes in type 1 diabetes mellitus: increased prevalence and relation to vascular complications.

Authors:  E Ahmed; S Nityanand; A Mustafa; K Brismar; A K Lefvert
Journal:  Clin Exp Immunol       Date:  1999-02       Impact factor: 4.330

4.  Serum complement C3 has a stronger association with insulin resistance than high sensitive C-reactive protein in non-diabetic Chinese.

Authors:  Bangqiong Wang; Qifu Li; Yuanjuan Jiang; Zhoujun Liu; Li Zhong; Rong Luo; Qingfeng Cheng; Hua Qing
Journal:  Inflamm Res       Date:  2010-08-13       Impact factor: 4.575

Review 5.  Diabetic complications and dysregulated innate immunity.

Authors:  Dana T Graves; Rayyan A Kayal
Journal:  Front Biosci       Date:  2008-01-01

6.  The C3a anaphylatoxin receptor is a key mediator of insulin resistance and functions by modulating adipose tissue macrophage infiltration and activation.

Authors:  Yaël Mamane; Chi Chung Chan; Genevieve Lavallee; Nicolas Morin; Li-Jing Xu; JingQi Huang; Robert Gordon; Winston Thomas; John Lamb; Eric E Schadt; Brian P Kennedy; Joseph A Mancini
Journal:  Diabetes       Date:  2009-07-06       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.